Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
12/1996
12/19/1996WO1996040284A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
12/19/1996WO1996040274A2 Chelating polymers as contrast agents for medical imaging
12/19/1996WO1996040273A2 Conjugates of ferrites and oligonucleotides, which bond specifically to certain target structures
12/19/1996WO1996040253A2 Rna photocleavage using texaphyrins
12/19/1996WO1996040245A1 Improved delivery of diagnostic and therapeutic agents to a target site
12/19/1996WO1996040194A1 Stable formulations of mhc-peptide complexes
12/19/1996WO1996039937A1 Microfabricated devices for diagnostic applications
12/19/1996CA2232196A1 A method for preparing radiolabeled peptides
12/19/1996CA2223605A1 Stable formulations of mhc-peptide complexes
12/19/1996CA2223456A1 Chelating polymers as contrast agents for medical imaging
12/19/1996CA2222478A1 Microfabricated devices for diagnostic applications
12/19/1996CA2222183A1 Stable reagents for the preparation of radiopharmaceuticals
12/19/1996CA2221690A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
12/19/1996CA2221146A1 Structurally determined metallo-constructs and applications
12/18/1996EP0748229A1 Polychelants
12/18/1996EP0666736B1 Stabilization of fluorocarbon emulsions
12/18/1996CN1137927A PPM radioactive label medicine
12/17/1996US5585468 Substituted thioureas as bifunctional chelators
12/17/1996US5585269 Nucleotide sequence which encodes a receptor having tyrosine kinase activity
12/12/1996WO1996039622A1 Method for measuring intestinal integrity
12/12/1996WO1996039198A1 Iodinated neuroprobes for mapping monoamine reuptake sites
12/12/1996WO1996039185A1 Treatment and diagnosis of prostate cancer
12/12/1996WO1996039161A1 Multi-tyrosinated somatostatin analogs
12/12/1996WO1996039124A1 Polymer affinity systems for the delivery of cytotoxic materials and other compounds to sites of disease
12/12/1996WO1996030055A3 Radiolabeled peptides for diagnosis and therapy
12/12/1996CA2223291A1 Treatment and diagnosis of prostate cancer
12/12/1996CA2222962A1 Multi-tyrosinated somatostatin analogs
12/11/1996EP0747069A2 Implantable medical device
12/11/1996EP0746761A1 Process for stripping radon-220 from radioactive isotope mixture
12/11/1996EP0746340A1 Peptide-chelator conjugates
12/11/1996EP0583390B1 Detection of cardiovascular lesions
12/11/1996EP0510086B1 Interdigitation-fusion liposomes and gels
12/10/1996US5583220 Pyrole nitrogen-substituted texaphyrins
12/10/1996US5583219 Macrocyclic chelating agent
12/10/1996US5583212 Used as thiophosphorylating agents for antibodies that binds tumor-associated antigens
12/10/1996US5583206 Chelating polymers
12/10/1996US5582813 Iodine-containing fluorocarbon contrast agents
12/10/1996US5582172 Intravascular administering a particle carrier comprising an organic inner core surface grafted with carbohydrates specific bonding to lymph nodes
12/10/1996CA2060507C Factor xa based anticoagulant compositions
12/05/1996WO1996038185A1 Sequestered imaging agents
12/05/1996WO1996038178A1 Allogeneic and xenogeneic transplantation
12/05/1996CA2218877A1 Sequestered imaging agents
12/04/1996EP0745085A1 Texaphyrin metal complexes having improved functionalization
12/04/1996EP0745082A1 Substituted 1,3,8-triaza-spiro(4,5)-decan-4-one derivatives useful as preliminary stages in the production of pharmaceuticals
12/04/1996EP0745064A1 4,4-disubstituted piperidine derivatives useful as four-pointed ligands for complexing nuclides in nuclear medicine
12/04/1996EP0744894A1 Self-assembling multimeric nucleic acid constructs
12/04/1996EP0479920B1 Novel antibodies reactive with human carcinomas
12/04/1996CN1137323A Apparatus and method for preparation of radiopharmaceutical formulation
12/03/1996US5580543 Texaphyrins as radiation sensitizers
12/03/1996CA1338770C Vinyl substituted radiohalogen conjugates for protein labeling
11/1996
11/28/1996WO1996037516A1 Methods of treatment and diagnostic visualisation, particularly in cancer
11/28/1996WO1996037506A1 Method of tritium labeling oligonucleotides
11/28/1996WO1996037239A1 Peptide radiopharmaceutical applications
11/28/1996WO1996037224A1 Methods of treating colon cancer utilizing tumor-specific antibodies
11/28/1996CA2221935A1 Method of treating colon cancer utilizing tumor-specific antibodies
11/28/1996CA2219492A1 Peptide radiopharmaceutical applications
11/28/1996CA2219479A1 Methods of treatment and diagnostic visualisation, particularly in cancer
11/27/1996EP0743956A1 Pretargeting methods and compounds
11/27/1996EP0743861A1 Radiolabeled annexins
11/26/1996US5578583 Microemulsions used as vehicles for carrying chemotherapeutic agents to neoplastic cells
11/26/1996US5578482 Ligand growth factors that bind to the erbB-2 receptor protein and induce cellular responses
11/26/1996US5578325 Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
11/26/1996US5578289 Administering antibody-enzyme conjugate
11/26/1996US5578288 Metal-binding targeted polypeptide constructs
11/26/1996US5578287 Three-step pretargeting methods using improved biotin-active agent
11/21/1996WO1996036367A1 Composition and method for tumor imaging
11/21/1996WO1996036360A1 Immunoconjugates comprising single-chain variable region fragments of anti-cd-19 antibodies
11/21/1996CA2218898A1 Immunoconjugates comprising single-chain variable region fragments of anti-cd19 antibodies
11/20/1996EP0742823A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
11/20/1996EP0742724A1 Agent for marking bodily tissues
11/20/1996EP0430968B1 Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
11/20/1996CN1136313A Polyazacycloalkanes as dichelants
11/14/1996WO1996011712A3 Cell-specific gene delivery vehicles
11/13/1996EP0742014A1 MHC-peptide labelled conjugates
11/13/1996EP0741785A1 Methods and compositions for stimulating bone cells
11/13/1996EP0741748A1 Monoclonal antibodies specific to vegf receptors and uses thereof
11/13/1996EP0741747A1 Inhibitors of serine proteases, bearing a chelating group
11/13/1996EP0741580A1 Controlled release of pharmaceutically active substances for immunotherapy
11/13/1996EP0542903B1 Cocaine receptor binding ligands
11/12/1996US5574148 Rapid synthesis of radiolabeled pyrimidine nucleosides or nucleotides
11/12/1996US5574140 Hydrazino-type N2 S2 chelators
11/12/1996US5573748 Kit for use in preparing the chelate; container with glycylglycyl ligand, water soluble stannous salt, intermediate exchange ligand, water soluble technetium-99m pertechnetate
11/12/1996US5573747 Thiosemicarbazone ligand solution, elution from anionic exchange resin
11/12/1996CA1338721C Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
11/12/1996CA1338706C Monoclonal anti-human breast cancer antibodies suitable for imaging breast cancer
11/07/1996WO1996034873A1 Recombinant endotoxin-neutralizing proteins
11/07/1996WO1996034872A1 Iodine derivatives of monosaccharides useful as radiopharmaceutical products
11/07/1996WO1996034632A1 Method of establishing the optimal radiation dose for radiopharmaceutical treatment of disease
11/07/1996CA2219999A1 Method of establishing the optimal radiation dose for radiopharmaceutical treatment of disease
11/06/1996EP0740581A1 Particulate material
11/06/1996EP0413763B1 Method for the production of monoclonal antibodies utilizing a germfree animal
11/06/1996CN1134843A Mouse antiamboceptor medicinal radionuclide I-131
11/06/1996CN1134842A Mouse antiamboceptor medicinal radionuclide Y-90
11/06/1996CN1134841A Mouse antiamboceptor medicinal radionuclide s-35
11/05/1996US5571713 Therapeutic treatment for inhibiting vascular restenosis
10/1996
10/31/1996WO1996033732A1 Multimeric, recombinant urease vaccine
10/31/1996DE19515212A1 Prodn. of radiofluorinated 2-fluoro-2-deoxy-glucose or -galactose
10/31/1996CA2219201A1 Multimeric, recombinant urease vaccine
10/30/1996EP0739355A1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
10/30/1996EP0739233A1 Process for separating carrier-free radionuclides from target liquids, its use and arrangement therefor
1 ... 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 ... 243